Bellevue Group’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-53,187	Closed	-$1.97M	–	179
2022 Q3	$1.97M	Buy	53,187 +18,187	+52%	+$673K	0.03%	123
2022 Q2	$665K	Buy	35,000 +19,000	+119%	+$361K	0.01%	144
2022 Q1	$432K	Buy	+16,000	New	+$432K	0.01%	158